Lilly’s Taltz scrapes win against Humira in psoriatic arthritis

Lilly’s Taltz scrapes win against Humira in psoriatic arthritis

Source: 
Pharmaforum
snippet: 

Eli Lilly’s Taltz has beaten AbbVie’s blockbuster Humira in a psoriatic arthritis study involving patients who hadn’t been treated before with a disease-modifying drug, but only just.